New anticancer agents with lower toxicity have been always urged because of drug resistance associated with overused chemotherapy agents. In a recent study, steviol, a colonic metabolite of natural sweetener and also a component in leaves of stevia rebaudiana bertoni, was found to possess intensive anticancer activity on the human gastrointestinal cancer cells.

Steviol inhibited six human gastrointestinal cancer cells intensively as 5-fluorouracil did at 100 μg/mL. The inhibition mechanism follows mitochondrial apoptotic pathway that was evidenced by increase of Bax/Bcl-2 ratio, activation of p21 and p53; and caspase 3-independent mechanism was also involved. These results are consistent with the miRNA expression analysis which was carried out using miRNA microarray technology. The most regulated miRNAs in the steviol treated gastrointestinal cancer cells were miR-203a-3p (log2 =1.32) and miR-6088 (log2 =-2.54) in HCT-116, miR-1268b (log2 =19.85) and miR-23c (log2 =-2.05) in MKN-45.

In view of the metabolic characteristics of steviol and its cytotoxicity on the cancer cells, steviol could be a chemotherapy agent potentially for cancer treatment.

 

Reference
J. Chen, Y. Xia, X. Sui, Q. Peng, T. Zhang, J. Li, J. Zhang (2018) Steviol, a natural product inhibits proliferation of the gastrointestinal cancer cells intensively Oncotarget doi: 10.18632/oncotarget.25233 [article]

Understanding the Contribution of Stem Cells in Pathophysiological States and Oncogenesis RNA Sequencing Identifies Molecular Mechanisms Behind Cold Resistance In P. Bournei